Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€2.84
20.09.21
€4.00
20.09.22
-13.38%
02.10.21

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Aya Gold & Silver Inc.

Start price
Target price
Perf. (%)
€5.90
20.09.21
-
20.09.22
-9.32%
02.10.21

Could be very worthwhile Investment >20% year
buy
Coupang Inc.

Start price
Target price
Perf. (%)
€24.85
19.09.21
€33.00
19.09.22
-4.99%
02.10.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Tomtom N.v.

Start price
Target price
Perf. (%)
€3.28
19.09.21
€5.00
19.09.22
-0.05%
02.10.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Ceotronics AG

Start price
Target price
Perf. (%)
€4.59
19.09.21
€8.00
19.09.22
-3.05%
02.10.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Innate Pharma

Start price
Target price
Perf. (%)
€6.61
18.09.21
€3.00
18.09.22
-22.01%
02.10.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€6.60
18.09.21
€3.00
18.09.22
-26.06%
02.10.21

Lower EBIT Margin than peer group
Bad rating
Increased challenges to pay loans and raise capital
Below average Management
micromobility.com Inc.

Start price
Target price
Perf. (%)
€693.90
18.09.21
€350.00
18.09.22
-22.18%
02.10.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
18.09.21
€2.00
18.09.22
-22.69%
02.10.21

Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
First Wave BioPharma Inc.

Start price
Target price
Perf. (%)
€675.52
18.09.21
€209.79
18.09.22
-25.47%
02.10.21

Low dividend yield expected
Bad rating
ROE lower than 10% per year
Sustainability is little important
buy
Porsche Automobil Holding SE

Start price
Target price
Perf. (%)
€61.54
07.02.21
-
07.02.22
39.97%
01.10.21

Top 10 in its market
Well known brand
Future proof or reliable business model
Capable Management
buy
Invesco Ltd.

Start price
Target price
Perf. (%)
€20.29
20.09.21
-
20.09.22
4.58%
01.10.21

Could be worthwhile Investment >10% per year
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€443.65
01.02.21
€490.00
01.02.22
18.54%
01.10.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
LPKF Laser & Electronics AG

Start price
Target price
Perf. (%)
€19.46
08.09.21
-
08.09.22
1.75%
30.09.21

Could be worthwhile Investment >10% per year
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.55
20.09.21
€4.00
20.09.22
-13.87%
30.09.21

Good culture
Probably not worthwhile Investment
Below average Management
Little innovation
buy
Camber Energy Inc.

Start price
Target price
Perf. (%)
€78.00
16.09.21
€105.00
16.09.22
70.51%
29.09.21

Could be worthwhile Investment >10% per year
buy
Fastned B.V.

Start price
Target price
Perf. (%)
€55.40
30.06.21
€58.00
30.06.22
-0.54%
29.09.21

Could be worthwhile Investment >10% per year
buy
CTS Eventim AG & Co. KGaA

Start price
Target price
Perf. (%)
€54.95
09.11.19
€55.00
04.11.21
19.20%
29.09.21

Could be worthwhile Investment >10% per year
buy
Maurel et Prom S.A.

Start price
Target price
Perf. (%)
€2.03
19.04.21
€2.20
19.04.22
12.10%
29.09.21

Could be worthwhile Investment >10% per year
buy
Lagardere S.C.A.

Start price
Target price
Perf. (%)
€20.62
03.06.21
€24.00
03.06.22
10.96%
29.09.21

Could be worthwhile Investment >10% per year
Editas Medicine Inc

Start price
Target price
Perf. (%)
€46.67
29.09.21
€35.00
31.10.22
-16.73%
29.09.21

Could be very worthwhile Investment >20% year
buy
POET Technologies Inc.

Start price
Target price
Perf. (%)
€6.29
27.01.21
€30.00
27.01.22
9.38%
29.09.21

Strong uniques
Very differentiated customer and product portfolio
Undervalued
Very Future proof/growth oriented business model
buy
Buzzi Unicem SpA

Start price
Target price
Perf. (%)
€22.75
27.06.21
€25.00
27.06.22
-13.49%
28.09.21

Could be worthwhile Investment >10% per year
buy
Clancy Exploration

Start price
Target price
Perf. (%)
€0.017
29.06.21
€0.025
-
28.09.21

Could be worthwhile Investment >10% per year
buy
Marin Software

Start price
Target price
Perf. (%)
€14.90
02.07.21
€18.00
02.07.22
-46.31%
28.09.21

Could be worthwhile Investment >10% per year